Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Second Heart Assist Announces Completion of Series D Financing

Mission Viejo, California, United States - 02-28-2023 (PR Distribution™) -

Salt Lake City, Utah –Second Heart Assist, Inc. a clinical stage medical device company, today announced completion of a $4.41 million Series D financing led by Vestech Securities LLC.  This brings total paid in cash capital to over $15.4 million.

Second Heart Assist, Inc. will use new funding to continue to advance testing of both its 1st generation Whisper TM catheter based circulatory assist pump and Freedom TM its 2nd generation wireless powered implant. Both products are based on the company’s patented aortic stent platform technology. 

The company is about to embark on a second round of clinical studies this time in treating patients with cardio-renal syndrome heart failure. Details of this new OUS study will be announced shortly. 

December 24th, 2022 the company received a Letter of Allowance from the United States Patent and Trademark office on the issuance of 21 new patent claims.  These newly issued patent claims add to over 100 previous patent claims that company has had issued or exclusively licensed.  The company believes it has the pre-eminent IP estate in the sector especially when it comes to a stable wireless powered implant that also maintains aortic wall pulsatility. 

"The Second Heart Assist, Inc. device pipeline is poised to provide valuable new tools to physicians managing patients in cardio-renal syndrome and heart failure.  These patients are a great challenge especially when diuretic resistant. New tools are certainly needed to provide better management.” said Dr. Leslie Miller, M.D Chief Medical Officer. 

“The entire Second Heart team is highly focused on completing our planned cardio-renal syndrome heart failure pilot study in North America and preparing for a subsequent pivotal Phase II multi-center study including full cGMP compliance in manufacturing.  This new funding should permit us to reach these goals in 2023.”  stated jointly Howard J. Leonhardt, Executive Chairman & CEO and Jeff Donofrio President 

About Second Heart Assist, Inc.:

Incorporated in 2017 Second Heart Assist, Inc. is focused on developing a pipeline of next generation percutaneous (non surgical) placed circulatory assist devices.  See www.secondheartinc.com for more information.  The Second Heart development project began within the Leonhardt's Launchpads innovation and startup launch accelerator program.

Contact:

Howard J. Leonhardt 
Executive Chairman & CEO
hleonhardt@secondheartinc.com 

Media Contacts:

Company Name: Second Heart Assist, Inc.
Full Name: Howard J. Leonhardt
Phone: (424) 291-2133
Email Address: Send Email
Website: http://www.secondheartinc.com

For the original news story, please visit https://www.prdistribution.com/news/second-heart-assist-announces-completion-of-series-d-financing/9565322.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.